Researchers have moved to cushion thousands of children in ongoing malaria drug trials from Covid-19 infections.
The pandemic hit when nearly 128,000 children in western Kenya were enrolled to take the world’s first malaria vaccine. “It is important we keep the trials going, but also crucial that everybody is safe,” said Kenya Medical Research Institute chief research officer Bernhards Ogutu.